|
|||||
|
|
Acute and subacute toxicity studies of CMICE-013, a novel iodinated rotenone-based myocardial perfusion tracer,in Sprague Dawley rats and Gottingen minipigs |
|
| Institution: | 1. Nordion Inc., 447 March Road, Ottawa, ON K2K 1X8, Canada;2. Canadian Molecular Imaging Center of Excellence (CMICE), University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, ON K1Y 4W7, Canada;3. Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, ON K1Y 4W7, Canada;4. Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada;1. Department of Environmental and Occupational Health Sciences, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, USA;2. Department of Molecular, Cellular, and Craniofacial Biology, ULSD, University of Louisville, Louisville, KY, USA;3. Department of Biostatistics and Bioinformatics, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, USA;4. Birth Defects Center, University of Louisville, Louisville, KY, USA;1. Department of Cranio-Maxillofacial Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands;2. GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands;3. Department of Radiology, Maastricht University Medical Centre, Maastricht, The Netherlands;4. Department of Radiation Oncology (MAASTRO), Maastricht University Medical Centre, Maastricht, The Netherlands |
| Abstract: | PurposeExtensive acute and subacute toxicities studies are required to evaluate the toxicological profile of the novel cardiac perfusion imaging tracer 123I-CMICE-013 to support applications for clinical trials.MethodsSprague-Dawley rats and Gottingen minipigs received injections of non-radioactive 127I-CMICE-013 at two dosage levels of 1 and 5 μg/kg, and vehicle buffer as control. In the acute toxicity studies, each animal was injected on two occasions 24 h apart and then underwent a 14-day recovery period; in the subacute study, animals received daily injections for 14 days continuously. The health status and mortality of test animals were monitored daily and body weight, food consumption, physiological and biochemical parameters were measured at various time points during the study. Animals were euthanized at the end of the studies and dissected for pathologic examination of organs and tissues.ResultsThe acute and subacute administrations of injections of the non-radioactive CMICE-013 in rats and minipigs were well tolerated. Little to no dosing-related adverse effects were observed in animal body and organ weights, hematology, coagulation, clinical chemistry, urinalysis, ophthalmoscopy, electrocardiograms, heart rates, blood pressure, macroscopic and microscopic examination of the preserved animal tissues including the brain.ConclusionThe lack of adverse effects from acute and subacute dosing suggest that the CMICE-013 injection solution has a reasonable safety margin within the designed concentration range to be utilized in imaging applications. The dosage level of 5 μg/kg was considered the no adverse effect level for both rats and minipigs based on our acute and subacute studies. |
| Keywords: | Preclinical toxicity study CMICE-013 Myocardial perfusion tracer Iodinated rotenone MPI"} {"#name":"keyword" "$":{"id":"kwrd0035"} "$$":[{"#name":"text" "_":"myocardial perfusion imaging RBC"} {"#name":"keyword" "$":{"id":"kwrd0045"} "$$":[{"#name":"text" "_":"red blood cell HGB"} {"#name":"keyword" "$":{"id":"kwrd0055"} "$$":[{"#name":"text" "_":"hemoglobin HCT"} {"#name":"keyword" "$":{"id":"kwrd0065"} "$$":[{"#name":"text" "_":"hematocrit MCV"} {"#name":"keyword" "$":{"id":"kwrd0075"} "$$":[{"#name":"text" "_":"mean corpuscular volume MCH"} {"#name":"keyword" "$":{"id":"kwrd0085"} "$$":[{"#name":"text" "_":"mean corpuscular hemoglobin MCHC"} {"#name":"keyword" "$":{"id":"kwrd0095"} "$$":[{"#name":"text" "_":"mean corpuscular hemoglobin concentration RDW"} {"#name":"keyword" "$":{"id":"kwrd0105"} "$$":[{"#name":"text" "_":"red cell distribution width HDW"} {"#name":"keyword" "$":{"id":"kwrd0115"} "$$":[{"#name":"text" "_":"hemoglobin distribution width PLT"} {"#name":"keyword" "$":{"id":"kwrd0125"} "$$":[{"#name":"text" "_":"platelets WBC"} {"#name":"keyword" "$":{"id":"kwrd0135"} "$$":[{"#name":"text" "_":"white blood cells NEUT"} {"#name":"keyword" "$":{"id":"kwrd0145"} "$$":[{"#name":"text" "_":"neutrophils LYMPH"} {"#name":"keyword" "$":{"id":"kwrd0155"} "$$":[{"#name":"text" "_":"lymphocytes MONO"} {"#name":"keyword" "$":{"id":"kwrd0165"} "$$":[{"#name":"text" "_":"monocytes EOS"} {"#name":"keyword" "$":{"id":"kwrd0175"} "$$":[{"#name":"text" "_":"eosinophils BASO"} {"#name":"keyword" "$":{"id":"kwrd0185"} "$$":[{"#name":"text" "_":"basophils LUC"} {"#name":"keyword" "$":{"id":"kwrd0195"} "$$":[{"#name":"text" "_":"large unstained cells RETIC"} {"#name":"keyword" "$":{"id":"kwrd0205"} "$$":[{"#name":"text" "_":"reticulocytes PT"} {"#name":"keyword" "$":{"id":"kwrd0215"} "$$":[{"#name":"text" "_":"Prothrombin Time APTT"} {"#name":"keyword" "$":{"id":"kwrd0225"} "$$":[{"#name":"text" "_":"Activated Partial Thromboplastin Time Na"} {"#name":"keyword" "$":{"id":"kwrd0235"} "$$":[{"#name":"text" "_":"sodium K"} {"#name":"keyword" "$":{"id":"kwrd0245"} "$$":[{"#name":"text" "_":"potassium Cl"} {"#name":"keyword" "$":{"id":"kwrd0255"} "$$":[{"#name":"text" "_":"chloride CREA"} {"#name":"keyword" "$":{"id":"kwrd0265"} "$$":[{"#name":"text" "_":"creatinine TP"} {"#name":"keyword" "$":{"id":"kwrd0275"} "$$":[{"#name":"text" "_":"total protein ALB"} {"#name":"keyword" "$":{"id":"kwrd0285"} "$$":[{"#name":"text" "_":"albumin GLOB"} {"#name":"keyword" "$":{"id":"kwrd0295"} "$$":[{"#name":"text" "_":"globulin A/G"} {"#name":"keyword" "$":{"id":"kwrd0305"} "$$":[{"#name":"text" "_":"albumin/globulin ratio BIL-T"} {"#name":"keyword" "$":{"id":"kwrd0315"} "$$":[{"#name":"text" "_":"bilirubin (total) CA"} {"#name":"keyword" "$":{"id":"kwrd0325"} "$$":[{"#name":"text" "_":"calcium PHOS"} {"#name":"keyword" "$":{"id":"kwrd0335"} "$$":[{"#name":"text" "_":"phosphorus AST"} {"#name":"keyword" "$":{"id":"kwrd0345"} "$$":[{"#name":"text" "_":"aspartate aminotransferase ALT"} {"#name":"keyword" "$":{"id":"kwrd0355"} "$$":[{"#name":"text" "_":"alanine aminotransferase ALP"} {"#name":"keyword" "$":{"id":"kwrd0365"} "$$":[{"#name":"text" "_":"alkaline phosphatise GLUC"} {"#name":"keyword" "$":{"id":"kwrd0375"} "$$":[{"#name":"text" "_":"glucose CHOL"} {"#name":"keyword" "$":{"id":"kwrd0385"} "$$":[{"#name":"text" "_":"cholesterol (total) TRIG"} {"#name":"keyword" "$":{"id":"kwrd0395"} "$$":[{"#name":"text" "_":"triglycerides NOEL"} {"#name":"keyword" "$":{"id":"kwrd0405"} "$$":[{"#name":"text" "_":"no observed effect level NOAEL"} {"#name":"keyword" "$":{"id":"kwrd0415"} "$$":[{"#name":"text" "_":"no adverse effect level |
| 本文献已被 ScienceDirect 等数据库收录！ | |